# Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.

> **NCT05282082** · — · COMPLETED · sponsor: **Erasmus Medical Center** · enrollment: 2105 (actual)

## Conditions studied

- Pseudomonas Aeruginosa
- Colonization, Asymptomatic
- Nosocomial Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05282082
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 2105 (ACTUAL)
- **Last updated:** 2026-03-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05282082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05282082, "Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05282082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*